Redmile Group Increases Stake to 9.9% with $8.4M Investment in Shattuck Labs
STTK has more than doubled off its 52-week low of $0.712.
Summary
Institutional investor Redmile Group has increased its stake in Shattuck Labs to 9.9% by investing over $8.4 million in warrant exercises and the recent public offering.
Key Events · Ownership and Investor Activity · STTK
-
Increased Beneficial Ownership
Redmile Group, LLC and Jeremy C. Green now beneficially own 9,819,084 shares, representing 9.9% of the company's common stock.
-
Significant Investment
Redmile Funds invested approximately $8.44 million through warrant exercises and participation in the recent underwritten public offering.
-
Warrant Exercises
On June 3, 2026, Redmile Funds exercised pre-funded warrants for 1,012,203 shares (cashless). On June 9, 2026, they exercised common warrants for 340,106 shares and pre-funded warrants for 3,757,624 shares, paying $4.44 million.
-
Public Offering Participation
On June 9, 2026, Redmile Funds acquired pre-funded warrants for 1,000,000 shares in the underwritten offering for approximately $4.0 million.
Analysis · STTK · Life Sciences
Redmile Group, a significant institutional investor, increased its beneficial ownership in Shattuck Labs to 9.9% through warrant exercises and participation in the recent $86.25 million public offering. This $8.4 million investment demonstrates strong conviction from a major holder, especially as it occurred alongside a dilutive capital raise.
At the time of this filing, STTK was trading at $4.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $320.5M. The 52-week trading range was $0.71 to $8.33. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.